NRG 200 Midterm Exam Prep Document | 2026/2027 Edition
| 250 Verified Questions
NRG 200 Pharmacology for Human Caring Nursing Midterm Exam 2026-2027 Questions and Answers Already
Graded A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This test bank for NRG 200 Pharmacology for Human Caring Nursing contains 250 verified midterm
exam questions with detailed rationales and distractors. The document is designed to assess and
reinforce understanding of pharmacological principles within a holistic, human-centered care
framework. Aligned with the latest NCLEX and ATI competencies, it covers pharmacokinetics, drug
classifications, nursing implications, and patient education. Perfect for students seeking to master safe
medication administration and achieve a top grade on the midterm exam.
Key Features:
Pharmacokinetics & Pharmacodynamics
Nursing Implications & Patient Education
Drug Classifications & Interactions
Safety & Quality Improvement
Ethical & Cultural Considerations
Dosage Calculations & Administration
Updates for 2026:
- Updated to reflect 2026-2027 nursing guidelines
- Integrated latest evidence-based pharmacology practices
- Expanded rationales with distractor analysis for deeper learning
- Realigned with modern nursing competencies and human caring philosophy
- Added new questions on compassionate medication management
Abstract:
This comprehensive test bank for NRG 200 Pharmacology for Human Caring Nursing Midterm Exam comprises
250 meticulously verified questions. The document is designed to evaluate students' understanding of
pharmacological principles within a human caring framework. Each question integrates core concepts of
pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring, emphasized through a holistic nursing
lens. The questions reflect current NCLEX-RN and ATI competencies, ensuring alignment with professional
standards. Detailed rationales and distractors are provided to reinforce critical thinking and clinical reasoning.
This resource is essential for achieving a thorough grasp of safe medication administration and patient-centered
care.
Keywords:
Pharmacology, Human Caring, NRG 200, Midterm Exam, Test Bank, Nursing, Drug Calculations, Patient Safety
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
analysis of distractors to clarify common misconceptions.
Compliance Checklist:
All questions aligned with latest NCLEX-RN test plan
Updated for 2026-2027 curriculum
Includes both pharmacological theory and nursing application
Rationales support evidence-based practice
Page 1
, Covers ethical and cultural considerations in medication management
Questions reflect human caring philosophy
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics & 1-45 Absorption, Distribution, Metabolism, 18%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 46-85 Cholinergics, Anticholinergics, Adrenergics, 16%
Drugs Adrenergic Blockers
Cardiovascular & Renal Drugs 86-130 Antihypertensives, Diuretics, Cardiac 18%
Glycosides, Antiarrhythmics
Central Nervous System Drugs 131-170 Analgesics, Sedatives, Antidepressants, 16%
Antipsychotics
Endocrine & Metabolic Drugs 171-210 Insulin, Oral Hypoglycemics, Thyroid, 16%
Corticosteroids
Antimicrobial & 211-250 Antibiotics, Antifungals, Antivirals, Cancer 16%
Chemotherapeutic Drugs Drugs
Page 2
,Q1. A drug administered orally undergoes extensive first-pass metabolism in the liver,
resulting in a bioavailability of only 20%. Which adjustment would the nurse
anticipate for the equivalent intravenous dose?
A. Same dose as oral
B. Half the oral dose
C. One-fifth the oral dose
D. Double the oral dose
Correct Answer: C. One-fifth the oral dose
Rationale: First-pass metabolism reduces oral bioavailability; the IV dose bypasses the
liver. To achieve equivalent plasma levels, the IV dose is the oral dose multiplied by
bioavailability (0.2), so it is one-fifth of the oral dose.
Why Wrong:
A - Oral and IV doses differ due to first-pass effect; same dose would result in higher
levels IV.
B - Half the oral dose would be 50% of oral, but bioavailability is 20%, so half is too
high.
D - Double the oral dose would be 200% of oral, further increasing plasma levels, not
compensating for first-pass.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. A patient receiving an opioid agonist develops respiratory depression. Naloxone,
a competitive antagonist, is administered. Which pharmacologic effect explains the
reversal?
A. Activation of kappa receptors
B. Displacement of agonist from mu receptors
C. Increased metabolism of the opioid
D. Allosteric modulation of GABA receptors
Correct Answer: B. Displacement of agonist from mu receptors
Rationale: Naloxone competitively binds to mu opioid receptors with higher affinity,
displacing the agonist and reversing its effects without intrinsic activity. It does not
activate kappa or affect metabolism.
Why Wrong:
A - Kappa receptor activation does not reverse mu-mediated respiratory depression.
C - Naloxone does not alter drug metabolism.
D - Naloxone acts on opioid receptors, not GABA receptors.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 13
Page 3
, Q3. A patient receiving an anticholinergic medication for overactive bladder reports
blurred vision and dry mouth. Which receptor blockade causes these effects?
A. Muscarinic M2 in heart
B. Nicotinic Nn in autonomic ganglia
C. Muscarinic M3 in salivary glands and ciliary muscle
D. Nicotinic Nm at neuromuscular junction
Correct Answer: C. Muscarinic M3 in salivary glands and ciliary muscle
Rationale: M3 receptors mediate salivation and ciliary muscle contraction; their blockade
leads to dry mouth and blurred vision (cycloplegia). M2 blockade affects heart rate, while
nicotinic blockade causes different effects.
Why Wrong:
A - M2 blockade primarily affects cardiac rate, not salivary or ocular function.
B - Nn blockade affects autonomic ganglia, leading to widespread effects but not
specifically dry mouth and blurred vision.
D - Nm blockade causes skeletal muscle paralysis, not anticholinergic effects.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Q4. A patient with asthma requires a beta-blocker for hypertension. Which property
makes a cardioselective beta-1 blocker preferable?
A. Higher affinity for beta-2 receptors
B. Lower first-pass metabolism
C. Minimal blockade of beta-2 receptors in lungs
D. Additional alpha-blocking activity
Correct Answer: C. Minimal blockade of beta-2 receptors in lungs
Rationale: Cardioselective beta-1 blockers (e.g., metoprolol) have less effect on beta-2
receptors in bronchial smooth muscle, reducing risk of bronchospasm in asthmatics.
Why Wrong:
A - Higher affinity for beta-2 would worsen bronchospasm.
B - First-pass metabolism varies but is not the key reason for selectivity.
D - Alpha-blockade does not reduce bronchial effects; it may cause orthostasis.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 18
Q5. A patient with type 1 diabetes is prescribed insulin glargine once daily and insulin
lispro before meals. Which statement accurately describes the pharmacokinetic
rationale?
A. Glargine is a rapid-acting insulin for prandial coverage
B. Lispro provides a constant basal level
C. Glargine provides a peakless basal insulin level
Page 4
| 250 Verified Questions
NRG 200 Pharmacology for Human Caring Nursing Midterm Exam 2026-2027 Questions and Answers Already
Graded A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This test bank for NRG 200 Pharmacology for Human Caring Nursing contains 250 verified midterm
exam questions with detailed rationales and distractors. The document is designed to assess and
reinforce understanding of pharmacological principles within a holistic, human-centered care
framework. Aligned with the latest NCLEX and ATI competencies, it covers pharmacokinetics, drug
classifications, nursing implications, and patient education. Perfect for students seeking to master safe
medication administration and achieve a top grade on the midterm exam.
Key Features:
Pharmacokinetics & Pharmacodynamics
Nursing Implications & Patient Education
Drug Classifications & Interactions
Safety & Quality Improvement
Ethical & Cultural Considerations
Dosage Calculations & Administration
Updates for 2026:
- Updated to reflect 2026-2027 nursing guidelines
- Integrated latest evidence-based pharmacology practices
- Expanded rationales with distractor analysis for deeper learning
- Realigned with modern nursing competencies and human caring philosophy
- Added new questions on compassionate medication management
Abstract:
This comprehensive test bank for NRG 200 Pharmacology for Human Caring Nursing Midterm Exam comprises
250 meticulously verified questions. The document is designed to evaluate students' understanding of
pharmacological principles within a human caring framework. Each question integrates core concepts of
pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring, emphasized through a holistic nursing
lens. The questions reflect current NCLEX-RN and ATI competencies, ensuring alignment with professional
standards. Detailed rationales and distractors are provided to reinforce critical thinking and clinical reasoning.
This resource is essential for achieving a thorough grasp of safe medication administration and patient-centered
care.
Keywords:
Pharmacology, Human Caring, NRG 200, Midterm Exam, Test Bank, Nursing, Drug Calculations, Patient Safety
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
analysis of distractors to clarify common misconceptions.
Compliance Checklist:
All questions aligned with latest NCLEX-RN test plan
Updated for 2026-2027 curriculum
Includes both pharmacological theory and nursing application
Rationales support evidence-based practice
Page 1
, Covers ethical and cultural considerations in medication management
Questions reflect human caring philosophy
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics & 1-45 Absorption, Distribution, Metabolism, 18%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 46-85 Cholinergics, Anticholinergics, Adrenergics, 16%
Drugs Adrenergic Blockers
Cardiovascular & Renal Drugs 86-130 Antihypertensives, Diuretics, Cardiac 18%
Glycosides, Antiarrhythmics
Central Nervous System Drugs 131-170 Analgesics, Sedatives, Antidepressants, 16%
Antipsychotics
Endocrine & Metabolic Drugs 171-210 Insulin, Oral Hypoglycemics, Thyroid, 16%
Corticosteroids
Antimicrobial & 211-250 Antibiotics, Antifungals, Antivirals, Cancer 16%
Chemotherapeutic Drugs Drugs
Page 2
,Q1. A drug administered orally undergoes extensive first-pass metabolism in the liver,
resulting in a bioavailability of only 20%. Which adjustment would the nurse
anticipate for the equivalent intravenous dose?
A. Same dose as oral
B. Half the oral dose
C. One-fifth the oral dose
D. Double the oral dose
Correct Answer: C. One-fifth the oral dose
Rationale: First-pass metabolism reduces oral bioavailability; the IV dose bypasses the
liver. To achieve equivalent plasma levels, the IV dose is the oral dose multiplied by
bioavailability (0.2), so it is one-fifth of the oral dose.
Why Wrong:
A - Oral and IV doses differ due to first-pass effect; same dose would result in higher
levels IV.
B - Half the oral dose would be 50% of oral, but bioavailability is 20%, so half is too
high.
D - Double the oral dose would be 200% of oral, further increasing plasma levels, not
compensating for first-pass.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. A patient receiving an opioid agonist develops respiratory depression. Naloxone,
a competitive antagonist, is administered. Which pharmacologic effect explains the
reversal?
A. Activation of kappa receptors
B. Displacement of agonist from mu receptors
C. Increased metabolism of the opioid
D. Allosteric modulation of GABA receptors
Correct Answer: B. Displacement of agonist from mu receptors
Rationale: Naloxone competitively binds to mu opioid receptors with higher affinity,
displacing the agonist and reversing its effects without intrinsic activity. It does not
activate kappa or affect metabolism.
Why Wrong:
A - Kappa receptor activation does not reverse mu-mediated respiratory depression.
C - Naloxone does not alter drug metabolism.
D - Naloxone acts on opioid receptors, not GABA receptors.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 13
Page 3
, Q3. A patient receiving an anticholinergic medication for overactive bladder reports
blurred vision and dry mouth. Which receptor blockade causes these effects?
A. Muscarinic M2 in heart
B. Nicotinic Nn in autonomic ganglia
C. Muscarinic M3 in salivary glands and ciliary muscle
D. Nicotinic Nm at neuromuscular junction
Correct Answer: C. Muscarinic M3 in salivary glands and ciliary muscle
Rationale: M3 receptors mediate salivation and ciliary muscle contraction; their blockade
leads to dry mouth and blurred vision (cycloplegia). M2 blockade affects heart rate, while
nicotinic blockade causes different effects.
Why Wrong:
A - M2 blockade primarily affects cardiac rate, not salivary or ocular function.
B - Nn blockade affects autonomic ganglia, leading to widespread effects but not
specifically dry mouth and blurred vision.
D - Nm blockade causes skeletal muscle paralysis, not anticholinergic effects.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Q4. A patient with asthma requires a beta-blocker for hypertension. Which property
makes a cardioselective beta-1 blocker preferable?
A. Higher affinity for beta-2 receptors
B. Lower first-pass metabolism
C. Minimal blockade of beta-2 receptors in lungs
D. Additional alpha-blocking activity
Correct Answer: C. Minimal blockade of beta-2 receptors in lungs
Rationale: Cardioselective beta-1 blockers (e.g., metoprolol) have less effect on beta-2
receptors in bronchial smooth muscle, reducing risk of bronchospasm in asthmatics.
Why Wrong:
A - Higher affinity for beta-2 would worsen bronchospasm.
B - First-pass metabolism varies but is not the key reason for selectivity.
D - Alpha-blockade does not reduce bronchial effects; it may cause orthostasis.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 18
Q5. A patient with type 1 diabetes is prescribed insulin glargine once daily and insulin
lispro before meals. Which statement accurately describes the pharmacokinetic
rationale?
A. Glargine is a rapid-acting insulin for prandial coverage
B. Lispro provides a constant basal level
C. Glargine provides a peakless basal insulin level
Page 4
